
Illumina
Illumina are a global genomics and human health leader, innovating the future of precision health. They develop DNA sequencing and array-based life sciences technologies to enable boundless research discovery and personalized health. Illumina's products help to pioneer advances in oncology, genetic and infectious diseases, reproductive health and beyond.
Latest Illumina Content

Industry Insight
How Automation Can Help Avoid Next Generation Sequencing Errors Amid “The Great Resignation”
Learn how automation can help to obtain high-quality next generation sequencing research data.

News
New Approach to Large-Scale Single-Cell Profiling Developed
A new experimental pipeline has been developed to profile more cell types from different tissues, incorporating machine learning to collate the data and assemble the cell atlas.

Product News
Isolation of High Purity Exosomes
AMSBIO is a leading supplier of high purity exosomes using isolation methods including traditional differential and gradient ultracentrifugation, immunoaffinity, size exclusion chromatography as well as precipitation / low speed centrifugation.

Product News
TATAA Biocenter Partners With Olink To Add High Quality Proteomics With Unrivaled Throughput to Their Multiomics Offering
Olink Holding has announced its collaboration with TATAA Biocenter, launching Olink®Explore 3072 proteome profiling service.

News
Genetic Study of Over 57,000 People Provides Insights Into Severe COVID-19
Some 16 new genetic variants associated with severe Covid-19, including some related to blood clotting, immune response and intensity of inflammation, have been identified.

Industry Insight
The Genome in 3D – How Chromatin Conformation Impacts Gene Regulation
Three-dimensional interactions across the genome can impact gene expression, and understanding these interactions could offer new insights into oncogenic mechanisms.

Product News
SPT Labtech Paves the Way for a New Era of Genomics Liquid Handling
SPT Labtech has announced the launch of firefly®, an innovative liquid handling platform for next-generation sequencing library preparation.

Industry Insight
Alleviating the Burden of NGS Library Preparation
Next-generation sequencing (NGS) has undoubtedly revolutionized the genomics field and thanks to technological advances in recent years, laboratories around the globe are now applying NGS to a wide variety of applications. However, library sample preparation remains a key bottleneck and researchers are now looking to adopt automation solutions to alleviate this pain point. Technology Networks recently spoke with Paul Lomax, product manager at SPT Labtech to learn more about firefly®, the company’s new liquid handling platform for NGS library preparation.
Advertisement